Pospaļ, D <br/><br/>
[Effectiveness and safety of lansoprazole in the treatment of Zollinger-Ellison syndrome. First six months of treatment].  [electronic resource] 

 -  Gastroenterologie clinique et biologique  Oct 1998 
 - 801-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0399-8320 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles<br/>Adult<br/>Aged<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--adverse effects<br/>Female<br/>Gastric Acid--metabolism<br/>Gastric Mucosa--drug effects<br/>Humans<br/>Lansoprazole<br/>Male<br/>Middle Aged<br/>Omeprazole--adverse effects<br/>Proton Pump Inhibitors<br/>Secretory Rate--drug effects<br/>Zollinger-Ellison Syndrome--drug therapy